Closed
SectorHealthcare
2.49 -3.11
24h
Min
2.39
Max
2.58
Income | 27M -59M |
---|---|
Sales | 1.4M 7.6M |
EPS | -0.08 |
Profit margin | -783.62 |
Employees | 680 |
EBITDA | 946K -40M |
Recommendations | Buy |
---|---|
12 Months Forecast | +157.63% upside |
Next Earnings | 8 sie 2025 |
---|
Market Cap | -553M 1.9B |
---|---|
Previous open | 5.6 |
Previous close | 2.49 |
By Acuity
50%
50%
209 / 382 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 6.08 USD 157.63%
High 8 USD
Low 4.25 USD
Based on 3 Wall Street analysts offering 12 month price targets forImmunityBio Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$